884
Views
21
CrossRef citations to date
0
Altmetric
Clinical Focus: Neurological & Psychiatric Disorders - Original Research

Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease

, , &
Pages 509-522 | Received 14 Jun 2019, Accepted 13 Aug 2019, Published online: 28 Aug 2019

References

  • Dickson DW, Braak H, Duda JE, et al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria. Lancet Neurol. 2009 Dec;8(12):1150–1157.
  • Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13;68(11):812–819.
  • McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005 Dec 27;65(12):1863–1872.
  • Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates lewy body from alzheimer’s disease in early-stage dementia? Brain. 2006 Mar;129(Pt 3):729–735.
  • Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord. 2007 Sep 15;22(12):1689–1707. quiz 1837.
  • Onofrj M, Taylor JP, Monaco D, et al. Visual hallucinations in PD and Lewy body dementias: old and new hypotheses. Behav Neurol. 2013 Jan 1;27(4):479–493.
  • Fenelon G, Alves G. Epidemiology of psychosis in parkinson’s disease. J Neurol Sci. 2010 Feb 15;289(1–2):12–17.
  • Gallagher DA, Parkkinen L, O’Sullivan SS, et al. Testing an aetiological model of visual hallucinations in parkinson’s disease. Brain. 2011 Nov;134(Pt 11):3299–3309.
  • Collerton D, Perry E, McKeith I. Why people see things that are not there: a novel perception and attention deficit model for recurrent complex visual hallucinations. Behav Brain Sci. 2005 Dec;28(6):737–757. discussion 757-94.
  • Barnes J, Boubert L, Harris J, et al. Reality monitoring and visual hallucinations in Parkinson’s disease. Neuropsychologia. 2003;41(5):565–574.
  • Chang YP, Yang YH, Lai CL, et al. Event-related potentials in parkinson’s disease patients with visual hallucination. Parkinsons Dis. 2016;2016:1863508.
  • Ibarretxe-Bilbao N, Ramirez-Ruiz B, Junque C, et al. Differential progression of brain atrophy in parkinson’s disease with and without visual hallucinations. J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):650–657.
  • Manganelli F, Vitale C, Santangelo G, et al. Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson’s disease. Brain. 2009 Sep;132(Pt 9):2350–2355.
  • Koerts J, Borg MA, Meppelink AM, et al. Attentional and perceptual impairments in Parkinson’s disease with visual hallucinations. Parkinsonism Relat Disord. 2010 May;16(4):270–274.
  • Ramirez-Ruiz B, Junque C, Marti MJ, et al. Neuropsychological deficits in Parkinson’s disease patients with visual hallucinations. Mov Disord. 2006 Sep;21(9):1483–1487.
  • Ramirez-Ruiz B, Junque C, Marti MJ, et al. Cognitive changes in parkinson’s disease patients with visual hallucinations. Dement Geriatr Cogn Disord. 2007;23(5):281–288.
  • Shin S, Lee JE, Hong JY, et al. Neuroanatomical substrates of visual hallucinations in patients with non-demented parkinson’s disease. J Neurol Neurosurg Psychiatry. 2012 Dec;83(12):1155–1161.
  • Mori E, Shimomura T, Fujimori M, et al. Visuoperceptual impairment in dementia with lewy bodies. Arch Neurol. 2000 Apr;57(4):489–493.
  • Mosimann UP, Mather G, Wesnes KA, et al. Visual perception in parkinson disease dementia and dementia with Lewy bodies. Neurology. 2004 Dec 14;63(11):2091–2096.
  • Hepp DH, Da Hora CC, Koene T, et al. Cognitive correlates of visual hallucinations in non-demented parkinson’s disease patients. Parkinsonism Relat Disord. 2013 Sep;19(9):795–799.
  • Cagnin A, Gnoato F, Jelcic N, et al. Clinical and cognitive correlates of visual hallucinations in dementia with lewy bodies. J Neurol Neurosurg Psychiatry. 2013 May;84(5):505–510.
  • Gasca-Salas C, Clavero P, Garcia-Garcia D, et al. Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in parkinson’s disease patients with mild cognitive impairment. Hum Brain Mapp. 2016 Mar;37(3):968–977.
  • Heitz C, Noblet V, Cretin B, et al. Neural correlates of visual hallucinations in dementia with Lewy bodies. Alzheimers Res Ther. 2015;7(1):6.
  • Pezzoli S, Cagnin A, Bandmann O, et al. Structural and functional neuroimaging of visual hallucinations in lewy body disease: a systematic literature review. Brain Sci. 2017 Jul 15;7:7.
  • Bejr-Kasem H, Pagonabarraga J, Martinez-Horta S, et al. Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in parkinson’s disease. Mov Disord. 2019 Jan;34(1):78–86.
  • Goldman JG, Stebbins GT, Dinh V, et al. Visuoperceptive region atrophy independent of cognitive status in patients with parkinson’s disease with hallucinations. Brain. 2014 Mar;137(Pt 3):849–859.
  • Ramirez-Ruiz B, Marti MJ, Tolosa E, et al. Cerebral atrophy in parkinson’s disease patients with visual hallucinations. Eur J Neurol. 2007 Jul;14(7):750–756.
  • Sanchez-Castaneda C, Rene R, Ramirez-Ruiz B, et al. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson’s disease with dementia. Mov Disord. 2010 Apr 15;25(5):615–622.
  • Watanabe H, Senda J, Kato S, et al. Cortical and subcortical brain atrophy in parkinson’s disease with visual hallucination. Mov Disord. 2013 Oct;28(12):1732–1736.
  • Boecker H, Ceballos-Baumann AO, Volk D, et al. Metabolic alterations in patients with parkinson disease and visual hallucinations. Arch Neurol. 2007 Jul;64(7):984–988.
  • Pasquier J, Michel BF, Brenot-Rossi I, et al. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with lewy bodies. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1342–1348.
  • Perneczky R, Drzezga A, Boecker H, et al. Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. Dement Geriatr Cogn Disord. 2008;25(6):531–538.
  • Harding AJ, Broe GA, Halliday GM. Visual hallucinations in lewy body disease relate to lewy bodies in the temporal lobe. Brain. 2002 Feb;125(Pt 2):391–403.
  • Papapetropoulos S, McCorquodale DS, Gonzalez J, et al. Cortical and amygdalar lewy body burden in parkinson’s disease patients with visual hallucinations. Parkinsonism Relat Disord. 2006 May;12(4):253–256.
  • Gazzaley A, Nobre AC. Top-down modulation: bridging selective attention and working memory. Trends Cogn Sci. 2012 Feb;16(2):129–135.
  • Nobre AC, Mesulam MM. Large-scale networks for attentional Biases. In: Nobre AC, Kastner S, editors. The oxford handbook of attention. Oxford, UK: Oxford University Press; 2014. p. 105–151.
  • Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184.
  • Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. 2001 Nov;57(10 Suppl 3):S11–S26.
  • Moller JC, Korner Y, Dodel RC, et al. Pharmacotherapy of Parkinson’s disease in Germany. J Neurol. 2005 Aug;252(8):926–935.
  • Fahn S, Elton RL, UPDRS program members. Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent developments in Parkinson’s disease. New York: McMillan Healthcare Information; 1987. p. 153–164.
  • Ferman TJ, Smith GE, Boeve BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004 Jan 27;62(2):181–187.
  • Boeve BF, Molano JR, Ferman TJ, et al. Validation of the mayo sleep questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med. 2011 May;12(5):445–453.
  • Cummings JL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997 May;48(5 Suppl 6):S10–S16.
  • Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198.
  • Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci. 1987;6:5–120.
  • Lezak M, Howieson D, Bigler E, et al. Neuropsychological assessment. 5th. OU P, editor. New York: Oxford University Press; 2012.
  • Warrington EK, James M. The visual object and space perception battery. Bury St Edmunds: Thames Valley Test Company; 1991.
  • Caffarra P, Vezzadini G, Dieci F, et al. Rey-Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002 Mar;22(6):443–447.
  • Appollonio I, Leone M, Isella V, et al. The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci. 2005 Jun;26(2):108–116.
  • Dubois B, Slachevsky A, Litvan I, et al. The FAB: a frontal assessment battery at bedside. Neurology. 2000 Dec 12;55(11):1621–1626.
  • Caffarra P, Vezzadini G, Dieci F, et al. Una versione abbreviata del test di stroop: dati normativi nella popolazione italiana. Nuova Rivista Di Neurologia. 2002;12(4):111–115.
  • Novelli G, Papagno C, Capitani E, et al. Tre test clinici di memoria verbale a lungo termine. Taratura Su Soggetti Normali Archivio Di Psicologia Neurologia E Psichiatria. 1986;47(2):278–296.
  • Mondini S, Mapelli D, Vestri A, et al. Esame neuropsicologico breve. Una batteria di test per lo screening neuropsicologico. Milano: Raffaello Cortina Editore; 2003.
  • Orsini A, Grossi D, Capitani E, et al. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci. 1987 Dec;8(6):539–548.
  • Mori S, Oishi K, Jiang H, et al. Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage. 2008 Apr 1;40(2):570–582.
  • Hua K, Zhang J, Wakana S, et al. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage. 2008 Jan 1;39(1):336–347.
  • Wakana S, Caprihan A, Panzenboeck MM, et al. Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage. 2007 Jul 1;36(3):630–644.
  • Maldjian JA, Laurienti PJ, Burdette JH. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. NeuroImage. 2004 Jan;21(1):450–455.
  • Maldjian JA, Laurienti PJ, Kraft RA, et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage. 2003 Jul;19(3):1233–1239.
  • Lancaster JL, Rainey LH, Summerlin JL, et al. Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp. 1997;5(4):238–242.
  • Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp. 2000 Jul;10(3):120–131.
  • Asplund CL, Todd JJ, Snyder AP, et al. A central role for the lateral prefrontal cortex in goal-directed and stimulus-driven attention. Nat Neurosci. 2010 Apr;13(4):507–512.
  • Squire RF, Noudoost B, Schafer RJ, et al. Prefrontal contributions to visual selective attention. Annu Rev Neurosci. 2013 Jul;8(36):451–466.
  • Kravitz DJ, Saleem KS, Baker CI, et al. The ventral visual pathway: an expanded neural framework for the processing of object quality. Trends Cogn Sci. 2013 Jan;17(1):26–49.
  • DiCarlo JJ, Zoccolan D, Rust NC. How does the brain solve visual object recognition? Neuron. 2012 Feb 9;73(3):415–434.
  • Collerton D, Burn D, McKeith I, et al. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord. 2003;16(4):229–237.
  • Alzahrani H, Venneri A. Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson’s disease: A systematic review. J Neurol Sci. 2015 Sep 15;356(1–2):32–44.
  • Barnes J, Boubert L. Executive functions are impaired in patients with parkinson’s disease with visual hallucinations. J Neurol Neurosurg Psychiatry. 2008 Feb;79(2):190–192.
  • Grossi D, Trojano L, Pellecchia MT, et al. Frontal dysfunction contributes to the genesis of hallucinations in non-demented parkinsonian patients. Int J Geriatr Psychiatry. 2005 Jul;20(7):668–673.
  • Imamura K, Wada-Isoe K, Kitayama M, et al. Executive dysfunction in non-demented Parkinson’s disease patients with hallucinations. Acta Neurol Scand. 2008 Apr;117(4):255–259.
  • Santangelo G, Trojano L, Vitale C, et al. A neuropsychological longitudinal study in Parkinson’s patients with and without hallucinations. Mov Disord. 2007 Dec;22(6):2418–25.
  • Dirnberger G, Jahanshahi M. Executive dysfunction in parkinson’s disease: a review. J Neuropsychol. 2013 Sep;7(2):193–224.
  • Goldman JG, Holden SK, Litvan I, et al. Evolution of diagnostic criteria and assessments for Parkinson’s disease mild cognitive impairment. Mov Disord. 2018 Apr;33(4):503–510.
  • Corbetta M, Shulman GL. Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci. 2002 Mar 3;(3):201–215.
  • Serences JT, Schwarzbach J, Courtney SM, et al. Control of object-based attention in human cortex. Cereb Cortex. 2004 Dec;14(12):1346–1357.
  • Kehagia AA, Barker RA, Robbins TW. Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol. 2010 Dec;9(12):1200–1213.
  • Lewis SJ, Dove A, Robbins TW, et al. Cognitive impairments in early Parkinson’s disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci. 2003 Jul 16;23(15):6351–6356.
  • Wylie KP, Tregellas JR. The role of the insula in schizophrenia. Schizophr Res. 2010 Nov;123(2–3):93–104.
  • Neves Mde C, Duarte DG, Albuquerque MR, et al. Neural correlates of hallucinations in bipolar disorder. Braz J Psychiatry. 2016 Mar;38(1):1–5.
  • Blanc F, Noblet V, Philippi N, et al. Right anterior insula: core region of hallucinations in cognitive neurodegenerative diseases. PLoS One. 2014;9(12):e114774.
  • Menon V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn Sci. 2011 Oct;15(10):483–506.
  • Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010 Jun;214(5–6):655–667.
  • Catani M, Thiebaut de Schotten M. A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex. 2008 Sep;44(8):1105–1132.
  • Shine JM, Halliday GM, Naismith SL, et al. Visual misperceptions and hallucinations in Parkinson’s disease: dysfunction of attentional control networks? Mov Disord. 2011 Oct;26(12):2154–2159.
  • Aarsland D, Larsen JP, Tandberg E, et al. Predictors of nursing home placement in Parkinson’s disease: a population-based, prospective study. J Am Geriatr Soc. 2000 Aug;48(8):938–942.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.